Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials.

Abstract:

:One hundred seventy-nine patients with acute nonlymphoblastic leukemia in first remission (n = 75), chronic myelocytic leukemia in chronic or accelerated phase (n = 48) or leukemia in advanced stage (n = 56) were given HLA-identical marrow grafts and randomized to receive methotrexate or cyclosporine for prevention of graft-v-host disease (GVHD). The current report updates the three prospective trials with follow-ups ranging from 3.2 to 6.2 years after marrow grafting. Results were analyzed separately for each individual study and for all three studies combined. Overall, 40% of patients given cyclosporine and 55% of those given methotrexate developed acute GVHD (P = .13); the incidence of chronic GVHD was 42% and 48%, respectively (P = .67). Twenty-two percent of cyclosporine-treated patients and 30% of methotrexate-treated patients developed interstitial pneumonia of any etiology (P = .25), and the figures for cytomegalovirus pneumonia were 18% and 20%, respectively (P = .41). The overall incidence of leukemic relapse was 31% in cyclosporine-treated patients and 36% in methotrexate-treated patients (P = .75). The probabilities of survival for cyclosporine-v methotrexate-treated patients were comparable for all three study groups: 52% v 48% in patients with acute nonlymphoblastic leukemia (P = .42), 55% v 60% for those with chronic myelocytic leukemia (P = .61), 12% and 12% for those with advanced leukemia (P = .93), and 39% v 38% overall (P = .72). We conclude that cyclosporine and methotrexate are comparable regarding the likelihood of acute/chronic GVHD, interstitial pneumonia, leukemic relapse, and long-term survival.

journal_name

Blood

journal_title

Blood

authors

Storb R,Deeg HJ,Fisher L,Appelbaum F,Buckner CD,Bensinger W,Clift R,Doney K,Irle C,McGuffin R

subject

Has Abstract,Author List Incomplete

pub_date

1988-02-01 00:00:00

pages

293-8

issue

2

eissn

0006-4971

issn

1528-0020

journal_volume

71

pub_type

临床试验,杂志文章,随机对照试验

相关文献

BLOOD文献大全
  • Tumor necrosis factor (TNF)-alpha directly inhibits human erythropoiesis in vitro: role of p55 and p75 TNF receptors.

    abstract::Two tumor necrosis factor receptors (TNFRs) with molecular weights of 55 kD (TNFR-p55) and 75 kD (TNFR-p75) have recently been identified and cloned. In previous studies, TNFR-p55 has been shown to exclusively mediate bidirectional effects of TNF-alpha on committed bone marrow granulocyte-macrophage progenitor cells, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rusten LS,Jacobsen SE

    更新日期:1995-02-15 00:00:00

  • Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia.

    abstract::Chromosome 11q deletions are frequently observed in chronic lymphocytic leukemia (CLL) in association with progressive disease and a poor prognosis. A minimal region of deletion has been assigned to 11q22-q23. Trinucleotide repeats have been associated with anticipation in disease, and evidence of anticipation has bee...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.2.509

    authors: Auer RL,Jones C,Mullenbach RA,Syndercombe-Court D,Milligan DW,Fegan CD,Cotter FE

    更新日期:2001-01-15 00:00:00

  • Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?

    abstract::A series of alterations in the cellular genome affecting the expression or function of genes controlling cell growth and differentiation is considered to be the main cause of cancer. These mutational events include activation of oncogenes and inactivation of tumor suppressor genes. The elucidation of human cancer at t...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: Reuter CW,Morgan MA,Bergmann L

    更新日期:2000-09-01 00:00:00

  • Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia.

    abstract::Recently, point mutations in the gene of the granulocyte colony-stimulating factor (G-CSF) receptor have been reported in two patients with severe congenital neutropenia who developed acute myeloid leukemia (AML). We investigated the frequency of these specific G-CSF receptor mutations in patients with congenital neut...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tidow N,Pilz C,Teichmann B,Müller-Brechlin A,Germeshausen M,Kasper B,Rauprich P,Sykora KW,Welte K

    更新日期:1997-04-01 00:00:00

  • Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission.

    abstract::Childhood acute myeloid leukemia (AML) has a poor prognosis with standard chemotherapy. Allogeneic bone marrow transplantation (BMT) in remission improves the outlook only for the one third of patients with sibling donors. Autologous BMT with a lower morbidity and mortality is available to all. In this study, maximum ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tiedemann K,Waters KD,Tauro GP,Tucker D,Ekert H

    更新日期:1993-12-15 00:00:00

  • Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.

    abstract::We investigated the potential role of an immune reaction in mediating the dominant engraftment of 1 cord blood unit in 14 patients who received a double-unit cord blood transplantation (CBT). In 10 patients, dominant engraftment of a single donor unit emerged by day 28 after CBT. In 9 of these 10 patients, a significa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-07-228999

    authors: Gutman JA,Turtle CJ,Manley TJ,Heimfeld S,Bernstein ID,Riddell SR,Delaney C

    更新日期:2010-01-28 00:00:00

  • Extraembryonic expression of EPCR is essential for embryonic viability.

    abstract::The endothelial cell protein C receptor (EPCR) augments protein C activation by the thrombin-thrombomodulin complex. Deletion of the EPCR gene (Procr) in mice leads to embryonic lethality before embryonic day 10 (E10.0). EPCR is detected in the giant trophoblast cells at the feto-maternal boundary from E7.5 and weakly...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-01-0406

    authors: Li W,Zheng X,Gu JM,Ferrell GL,Brady M,Esmon NL,Esmon CT

    更新日期:2005-10-15 00:00:00

  • Isolation and characterization of complement receptor type 1 (CR1) storage vesicles from human neutrophils using antibodies to the cytoplasmic tail of CR1.

    abstract::Neutrophil (PMN) activation is associated with increased surface expression of several membrane proteins that are translocated from intracellular pools. Indirect evidence suggests that the intracellular storage pools of complement receptor type 1 (CR1) in resting PMN are distinct from traditional granules and may be t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kumar A,Wetzler E,Berger M

    更新日期:1997-06-15 00:00:00

  • Active amino acids of the Kell blood group protein and model of the ectodomain based on the structure of neutral endopeptidase 24.11.

    abstract::In addition to its importance in transfusion, Kell protein is a member of the M13 family of zinc endopeptidases and functions as an endothelin-3-converting enzyme. To obtain information on the structure of Kell protein we built a model based on the crystal structure of the ectodomain of neutral endopeptidase 24.11 (NE...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-05-1564

    authors: Lee S,Debnath AK,Redman CM

    更新日期:2003-10-15 00:00:00

  • The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy.

    abstract::Transplant-associated thrombotic microangiopathy (TA-TMA) occurs frequently after hematopoietic stem cell transplantation (HSCT) and can lead to significant morbidity and mortality. There are no data addressing individual susceptibility to TA-TMA. We performed a hypothesis-driven analysis of 17 candidate genes known t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-08-663435

    authors: Jodele S,Zhang K,Zou F,Laskin B,Dandoy CE,Myers KC,Lane A,Meller J,Medvedovic M,Chen J,Davies SM

    更新日期:2016-02-25 00:00:00

  • Transplant survivorship: a call to arms.

    abstract::In this issue of Blood, Sun and colleagues from the Bone Marrow Transplant Survivors Study report the chronic health outcomes of more than 1000 survivors of stem cell transplantation. Their results demonstrate a significant burden of chronic conditions among survivors. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2010-08-299420

    authors: Cutler C

    更新日期:2010-10-28 00:00:00

  • A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia.

    abstract::A noninferiority study was performed comparing low-dose and standard-dose prophylactic platelet transfusions. A double-blind randomized controlled trial (RCT) was performed in 6 sites in 3 countries. Thrombocytopenic adults requiring prophylactic platelet transfusion were randomly allocated to standard-dose (300-600 x...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2008-09-178236

    authors: Heddle NM,Cook RJ,Tinmouth A,Kouroukis CT,Hervig T,Klapper E,Brandwein JM,Szczepiorkowski ZM,AuBuchon JP,Barty RL,Lee KA,SToP Study Investigators of the BEST Collaborative.

    更新日期:2009-02-12 00:00:00

  • Human platelet cytoskeletons: specific content of glycolipids and phospholipids.

    abstract::The lipid composition of platelet cytoskeletons was analyzed. Triton X-100 (0.5%) was used to prepare cytoskeletons from thrombin-treated platelets. The lipid/protein ratio of platelet cytoskeletons was 0.260 and the phospholipid/protein ratio was 0.177, which were comparable to the ratios present in platelets. Howeve...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Schick PK,Tuszynski GP,Vander Voort PW

    更新日期:1983-01-01 00:00:00

  • c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations.

    abstract::Ectopic expression of c-Myc (Myc) in most primary cell types results in programmed cell death, and malignant transformation cannot occur without additional mutations that block apoptosis. The development of Myc-induced lymphoid tumors has been well studied and supports this model. Myc can be upregulated in acute myelo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-02-0734

    authors: Luo H,Li Q,O'Neal J,Kreisel F,Le Beau MM,Tomasson MH

    更新日期:2005-10-01 00:00:00

  • SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma.

    abstract::Mantle cell lymphoma (MCL) is one of the most aggressive lymphoid neoplasms whose pathogenesis is not fully understood. The neural transcription factor SOX11 is overexpressed in most MCL but is not detected in other mature B-cell lymphomas or normal lymphoid cells. The specific expression of SOX11 in MCL suggests that...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-06-438937

    authors: Vegliante MC,Palomero J,Pérez-Galán P,Roué G,Castellano G,Navarro A,Clot G,Moros A,Suárez-Cisneros H,Beà S,Hernández L,Enjuanes A,Jares P,Villamor N,Colomer D,Martín-Subero JI,Campo E,Amador V

    更新日期:2013-03-21 00:00:00

  • How I conduct a comprehensive chronic graft-versus-host disease assessment.

    abstract::Since the National Institutes of Health Chronic Graft-Versus-Host Disease (cGVHD) Consensus Project in 2005, a need has emerged to evaluate cGVHD more methodically, not only to make a cGVHD diagnosis, but also to accurately classify individual organ and global organ severity, at baseline and in follow-up so that subje...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-04-314815

    authors: Carpenter PA

    更新日期:2011-09-08 00:00:00

  • The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors.

    abstract::Previously, it was believed that megakaryocytopoiesis was regulated by two types of humoral factors: megakaryocyte colony-stimulating factor (MK-CSF), which acts on progenitors inducing their proliferation, and thrombopoietin (TPO), a megakaryocyte(s) (MK) maturational factor that induces platelet formation. The recen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Debili N,Wendling F,Katz A,Guichard J,Breton-Gorius J,Hunt P,Vainchenker W

    更新日期:1995-10-01 00:00:00

  • E-selectin mediates leukocyte rolling in interleukin-1-treated rabbit mesentery venules.

    abstract::The selectins are lectin-like cell surface glycoproteins that have been implicated in playing a crucial role in the initiation of leukocyte adhesion to endothelial cells (ECs) during inflammation. Binding of selectins under conditions of flow mediates leukocyte rolling, which in vivo is almost exclusively observed in ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Olofsson AM,Arfors KE,Ramezani L,Wolitzky BA,Butcher EC,von Andrian UH

    更新日期:1994-10-15 00:00:00

  • Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene.

    abstract::Pediatric-type follicular lymphoma (PTFL) is a variant of follicular lymphoma (FL) with distinctive clinicopathological features. Patients are predominantly young males presenting with localized lymphadenopathy; the tumor shows high-grade cytology and lacks both BCL2 expression and t(14;18) translocation. The genetic ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-03-703819

    authors: Schmidt J,Gong S,Marafioti T,Mankel B,Gonzalez-Farre B,Balagué O,Mozos A,Cabeçadas J,van der Walt J,Hoehn D,Rosenwald A,Ott G,Dojcinov S,Egan C,Nadeu F,Ramis-Zaldívar JE,Clot G,Bárcena C,Pérez-Alonso V,Endris V,Pe

    更新日期:2016-08-25 00:00:00

  • Interleukin-1, tumor necrosis factor, and the production of colony-stimulating factors by cultured mesenchymal cells.

    abstract::Although the genes for four hematopoietic colony-stimulating factors (CSFs) have been cloned, neither the mechanism of the regulation of their production nor their cellular origins have been established with certainty. Monocytes are known to produce colony-stimulating and burst-promoting activities, as well as several...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sieff CA,Niemeyer CM,Mentzer SJ,Faller DV

    更新日期:1988-10-01 00:00:00

  • Multiple cis elements regulate an alternative splicing event at 4.1R pre-mRNA during erythroid differentiation.

    abstract::The inclusion of exon 16 in the mature protein 4.1R messenger RNA (mRNA) is a critical event in red blood cell membrane biogenesis. It occurs during late erythroid development and results in inclusion of the 10-kd domain needed for stabilization of the spectrin/actin lattice. In this study, an experimental model was e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.13.3809

    authors: Deguillien M,Huang SC,Morinière M,Dreumont N,Benz EJ Jr,Baklouti F

    更新日期:2001-12-15 00:00:00

  • BCR-ABL/p62/SQSTM1: a cannibal embrace.

    abstract::In this issue of Blood, Goussetis et al identify autophagy as a new pathway for the degradation of the oncoprotein BCR-ABL. They show that the therapeutic drug arsenic trioxide (AS(2)O(3)) targets BCR-ABL for autophagic degradation via a p62/SQSTM1-dependent mechanism that is critical for the antileukemic effect of th...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2012-08-451492

    authors: Auberger P

    更新日期:2012-10-25 00:00:00

  • Ebf1 heterozygosity results in increased DNA damage in pro-B cells and their synergistic transformation by Pax5 haploinsufficiency.

    abstract::Early B-cell factor 1 (Ebf1) is a transcription factor with documented dose-dependent functions in normal and malignant B-lymphocyte development. To understand more about the roles of Ebf1 in malignant transformation, we investigated the impact of reduced functional Ebf1 dosage on mouse B-cell progenitors. Gene expres...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-12-617282

    authors: Prasad MA,Ungerbäck J,Åhsberg J,Somasundaram R,Strid T,Larsson M,Månsson R,De Paepe A,Lilljebjörn H,Fioretos T,Hagman J,Sigvardsson M

    更新日期:2015-06-25 00:00:00

  • Hematopoiesis in asymptomatic cats infected with feline immunodeficiency virus.

    abstract::Anemia and neutropenia often develop in cats that are infected with the feline immunodeficiency virus (FIV), a lentivirus biologically similar to the human immunodeficiency virus (HIV). To assess the role of FIV in the pathogenesis of these abnormalities, marrow culture studies were performed on nine asymptomatic, hem...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Linenberger ML,Shelton GH,Persik MT,Abkowitz JL

    更新日期:1991-10-15 00:00:00

  • Alpha4beta1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells.

    abstract::As B-cell chronic lymphocytic leukemia (B-CLL) progresses, malignant cells extravasate and infiltrate lymphoid tissues. Several molecules, including gelatinase B/MMP-9, contribute to these processes. Although mainly a secreted protease, some MMP-9 is present at the B-CLL cell surface and the function, mode of anchorin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-08-109249

    authors: Redondo-Muñoz J,Ugarte-Berzal E,García-Marco JA,del Cerro MH,Van den Steen PE,Opdenakker G,Terol MJ,García-Pardo A

    更新日期:2008-07-01 00:00:00

  • MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma.

    abstract::In this study, we show that microRNA-150 (miR-150) is significantly downregulated in advanced cutaneous T-cell lymphoma (CTCL), and that this downregulation is strongly associated with tumor invasion/metastasis. Inoculation of CTCL cell lines into nonobese diabetic/Shi-scid interleukin 2γ (IL-2γ) null mice led to CTCL...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-09-527739

    authors: Ito M,Teshima K,Ikeda S,Kitadate A,Watanabe A,Nara M,Yamashita J,Ohshima K,Sawada K,Tagawa H

    更新日期:2014-03-06 00:00:00

  • Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors.

    abstract::Outgrowth, long-term self-renewal, and terminal maturation of human erythroid progenitors derived from umbilical cord blood in serum-free medium can be modulated by steroid hormones. Homogeneous erythroid cultures, as characterized by flow cytometry and dependence on a specific mixture of physiologic proliferation fac...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-03-1002

    authors: Leberbauer C,Boulmé F,Unfried G,Huber J,Beug H,Müllner EW

    更新日期:2005-01-01 00:00:00

  • beta-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation.

    abstract::Control of intensity and duration of erythropoietin (Epo) signaling is necessary to tightly regulate red blood cell production. We have recently shown that the ubiquitin/proteasome system plays a major role in the control of Epo-R signaling. Indeed, after Epo stimulation, Epo-R is ubiquitinated and its intracellular p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-10-055350

    authors: Meyer L,Deau B,Forejtníková H,Duménil D,Margottin-Goguet F,Lacombe C,Mayeux P,Verdier F

    更新日期:2007-06-15 00:00:00

  • Interleukin-2 may induce prolonged remissions in advanced acute myelogenous leukemia.

    abstract::The administration of interleukin-2 (IL-2) may induce complete remissions in acute myelogenous leukemia (AML) patients with a low proportion of residual bone marrow (BM) blasts. To confirm this preliminary observation, we treated 14 AML patients with advanced disease and with a residual BM blastosis that ranged betwee...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Meloni G,Foa R,Vignetti M,Guarini A,Fenu S,Tosti S,Tos AG,Mandelli F

    更新日期:1994-10-01 00:00:00

  • The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.

    abstract::The functions of the alphaC domains of fibrinogen in clotting and fibrinolysis, which have long been enigmatic, were determined using recombinant fibrinogen truncated at Aalpha chain residue 251. Scanning electron microscopy and confocal microscopy revealed that the fibers of alpha251 clots were thinner and denser, wi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-05-2150

    authors: Collet JP,Moen JL,Veklich YI,Gorkun OV,Lord ST,Montalescot G,Weisel JW

    更新日期:2005-12-01 00:00:00